Schlesinger Michael A.'s Form 4 filing
Ortho Clinical Diagnostics Holdings plc (OCDX) · filed Aug 18, 2021
- Accession no.
- 0001209191-21-052290
- Filed
- Aug 18, 2021
- Trade date
- Aug 16-18, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $906.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schlesinger Michael A.CIK 0001839441 | Officer (EVP, GC and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Ordinary Shares, $0.00001 par value | MOption exerciseAcquired | +4,000 | $6.28 | +$25,120 | 91,637 | Direct | |
| Aug 16, 2021 | Ordinary Shares, $0.00001 par value | SSaleDisposed | −4,000 | $20.03F2,F3 | −$80,120 | 87,637 | Direct | |
| Aug 18, 2021 | Ordinary Shares, $0.00001 par value | MOption exerciseAcquired | +41,015 | $6.28 | +$257,574.2 | 128,652 | Direct | |
| Aug 18, 2021 | Ordinary Shares, $0.00001 par value | SSaleDisposed | −41,015 | $20.14F2,F4 | −$826,042.1 | 87,637 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Ordinary Shares, $0.00001 par value | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 334,522 | Direct | |
| Aug 18, 2021 | Ordinary Shares, $0.00001 par value | MOption exerciseDisposed | −41,015 | $0.00 | $0 | 293,507 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
Referenced by the price of 2 transactions in Table I.
- F3
Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.1500.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.3200.
Referenced by the price of 1 transaction in Table I.